Guided Therapeutics Inc. has announced the receipt of a $100,000 payment from Shandong Yaohua Medical Instrument Corporation $(SMI.AU)$ via its investment partners. This payment is part of a series of transactions aimed at supporting the commercialization of the LuViva Advanced Cervical Scan in China. The agreement with SMI extends the commercialization efforts of LuViva in China, contingent upon receiving regulatory approval by September this year. Part of the funds will be allocated to supplying SMI and its partner distributors in China with necessary electronic components for LuViva accessories.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.